Evolution of the Average Target: GE HealthCare Technologies Inc.

Evolution of the Target Price: GE HealthCare Technologies Inc.

Changes in Analyst Recommendations: GE HealthCare Technologies Inc.

c288a7b5f33c55ed0621b85c2.uLOKAo4GRQnbqNFMWi8RaBcltbIQuRCIF7RYUeg2yMM.2YD6Z9tPFGKpzZ9_d393PUdN8sEh9lPRbec8C6pemob59LxL4mEWQJPZsg~8fb28e989cef51fb4b420def879b1038
01/05 BNP Paribas Adjusts GE Healthcare Technologies Price Target to $88 From $95 MT
30/04 Rothschild & Co Redburn Adjusts Price Target on GE Healthcare Technologies to $98 From $110 MT
30/04 Barclays Adjusts Price Target on GE Healthcare Technologies to $78 From $87 MT
30/04 Citigroup Adjusts Price Target on GE Healthcare Technologies to $65 From $80 MT
30/04 Jefferies Adjusts Price Target on GE Healthcare Technologies to $90 From $105 MT
30/04 Mizuho Adjusts Price Target on GE Healthcare Technologies to $80 From $90 MT
30/04 JPMorgan Adjusts Price Target on GE Healthcare Technologies to $65 From $80 MT
30/04 Wells Fargo Adjusts Price Target on GE Healthcare Technologies to $75 From $97 MT
30/04 Piper Sandler Adjusts Price Target on GE Healthcare Technologies to $74 From $88 MT
30/04 Stifel Adjusts Price Target on GE Healthcare Technologies to $80 From $98 MT
30/04 Evercore ISI Adjusts Price Target on GE Healthcare Technologies to $80 From $85 MT
30/04 HSBC Adjusts Price Target on GE Healthcare Technologies to $90 From $100 MT
30/04 Oppenheimer Adjusts Price Target on GE Healthcare Technologies to $85 From $89, Maintains Outperform Rating MT
30/04 Goldman Sachs Downgrades GE Healthcare Technologies to Neutral From Buy, Adjusts PT to $65 From $81 MT
29/04 BTIG Cuts Price Target on GE Healthcare Technologies to $80 From $85, Maintains Buy Rating MT
17/04 Piper Sandler Adjusts GE Healthcare Technologies PT to $88 From $96, Maintains Overweight Rating MT
13/04 BTIG Research Adjusts GE Healthcare Technologies PT to $85 From $91, Maintains Buy Rating MT
13/04 Mizuho Securities Adjusts GE Healthcare Technologies PT to $90 From $95, Maintains Outperform Rating MT
08/04 Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $81 From $97, Maintains Buy Rating MT
07/04 Citigroup Adjusts GE Healthcare Technologies PT to $80 From $84, Maintains Neutral Rating MT
06/04 Evercore ISI Adjusts GE Healthcare Technologies PT to $85 From $98, Maintains Outperform Rating MT
11/03 Citigroup Adjusts PT on GE Healthcare Technologies to $84 From $88, Maintains Neutral Rating MT
04/03 Argus Adjusts Price Target on GE Healthcare Technologies to $95 From $90, Maintains Buy Rating MT
06/02 Rothschild & Co Redburn Adjusts Price Target on GE Healthcare Technologies to $110 From $108, Maintains Buy Rating MT
06/02 BNP Paribas Adjusts Price Target on GE Healthcare Technologies to $95 From $92, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+25.96%
+33.36%
+28.21%
+46.14%
+57.96%
+21.5%
+55.24%
+11.88%
+38.98%
+42.23%
Average +36.15%
Weighted average by Cap. +36.84%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
63.47USD
Average target price
79.95USD
Spread / Average Target
+25.96%
High Price Target
98.00USD
Spread / Highest target
+54.40%
Low Price Target
65.00USD
Spread / Lowest Target
+2.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BNP Paribas
Rothschild & Co Redburn
Barclays
Citigroup
Jefferies & Co.
Mizuho Securities
HSBC
JPMorgan Chase
Wells Fargo Securities
Piper Sandler
Stifel Nicolaus
Evercore ISI
Oppenheimer
Goldman Sachs
BTIG
Argus
UBS
Morgan Stanley
BNP Paribas Exane
DBS Bank
Redburn Atlantic
BofA Securities
Redburn
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
63.47USD
Average target price
79.95USD
Spread / Average Target
+25.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GEHC Stock
  4. Consensus GE HealthCare Technologies Inc.